Vivalis Strengthens its Intellectual Property Portfolio

Vivalis (NYSE-Euronext : VLS) has recently completed official arrangements to license platform technology from North Carolina State University (NCSU) describing a method of producing undifferentiated avian cell cultures using avian primordial germ (PGC) cells. This new license related to culture processes & culture media for avian stem cells supplements the 2 licences already signed with NORTH CAROLINA STATE UNIVERSITY in 2002.

MORE ON THIS TOPIC